NUTXNutex Health Inc.
What is the market doing?
No clear lean: in an uptrend, but a crowded short (+17% of shares).
In an uptrend, above its rising 50- and 200-day averages. Price is +39% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
A crowded short, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How NUTX is trading
Nutex Health Inc. is +115% over the past year while the S&P 500 is +18%: 96 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +39%
vs 200-day average · a clear uptrend
- RSI (14)
- 53
RSI (14) · neutral
- Below its 52-week high
- 8.3%
Below its 52-week high
Details›
- Last close2026-10-09
- $206.30
- 1 monthS&P 500 +2.7%
- +5.6%
- 1 yearS&P 500 +18%
- +115%
- vs 50-day average$193.69
- +6.5%
- 52-week high
- $225.00
- 52-week low
- $87.01
- Annualised volatility
- 106%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$43K
| Year | Return |
|---|---|
| 2026 (year to date) | +25% |
| 2025 | +419% |
| 2024 | +17% |
| 2023 | −91% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 4 | 1 of 4 | −4.1% |
| Feb | 4 | 2 of 4 | −5.3% |
| Mar | 4 | 0 of 4 | −17% |
| Apr | 4 | 2 of 4 | +14% |
| May | 5 | 4 of 5 | +11% |
| Jun | 5 | 1 of 5 | −19% |
| Jul | 5 | 2 of 5 | −3.4% |
| Aug | 5 | 3 of 5 | +32% |
| Sep | 5 | 3 of 5 | −6.8% |
| Oct | 5 | 3 of 5 | −5.0% |
| Nov | 4 | 2 of 4 | +36% |
| Dec | 4 | 2 of 4 | +11% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.